Pfizer, Lilly And Merck Strike Up Cancer Research Partnership In Asia
This article was originally published in The Pink Sheet Daily
Executive Summary
The not-for-profit Asian Cancer Research Group will focus initially on identifying biomarkers for lung and gastric cancers.
You may also be interested in...
Biomarkers For Alzheimer's, Parkinson's Disease To Be Developed By Industry Coalition Through First-Of-A-Kind Clinical Data Exchange
Unable to defeat Alzheimer's Disease and Parkinson's Disease, companies have joined forces to come up with new research tools
Big Pharma Stretches To Reshape Itself To Enter Asia With Flexible, Multiple-Partner Networks – Singapore Conference
SINGAPORE - As big pharma looks across Asia for new ways of doing business, execs from the top pharma companies agreed that having people on the ground in Asia is critical and that companies are moving away from being fully integrated pharma companies to becoming fully integrated pharma networks
Asian CROs On The March, But Tie-Ups Carry Risk: Analyst
SAN FRANCISCO - Pointing to the potential for a "perfect storm" in China and Asia with regard to contract research organizations' growth, Lehman Brothers analyst Douglas Tsao switched his metaphor to bolster the warning